| Bobbi J Mclain, CFNP | |
|
735 Wilson St, Brewer, ME 04412-1000 | |
| (207) 404-8100 | |
| (207) 947-0435 |
| Full Name | Bobbi J Mclain |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 735 Wilson St, Brewer, Maine |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104535681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | CNP231006 (Maine) | Primary |
| Entity Name | Penobscot Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1427169010 PECOS PAC ID: 0143212670 Enrollment ID: O20040819000698 |
News Archive
A new HIV study shows how competition among the human immune system's T cells allows the virus to escape destruction and eventually develop into full-blown AIDS.
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
People can become allergically sensitized straight from birth. "Early screening is therefore important to detect allergies early so that steps can be taken to prevent serious forms of illness developing," say the MedUni Vienna allergy researchers, speaking on the occasion of World Immunology Day on 29 April and the current WHO World Immunization Week.
The Senate is scheduled to proceed with consideration of the Obama administration pick to take over the Department of Health and Human Services.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Bobbi J Mclain, CFNP Po Box 1599, Bangor, ME 04402-1599 Ph: (207) 404-8200 | Bobbi J Mclain, CFNP 735 Wilson St, Brewer, ME 04412-1000 Ph: (207) 404-8100 |
News Archive
A new HIV study shows how competition among the human immune system's T cells allows the virus to escape destruction and eventually develop into full-blown AIDS.
Promedior, Inc., a clinical stage biotechnology company developing novel therapeutics for the treatment of fibrosis, today announced that principal investigator, Srdan Verstovsek, MD, PhD, will present interim data from the Company's ongoing Phase 2 clinical trial of its lead product candidate, PRM-151, for the treatment of myelofibrosis, in a poster presentation on June 2, 2014 at the American Society for Clinical Oncology 2014 Annual Meeting.
Upsher-Smith Laboratories, Inc. announced that it has received U.S. Food and Drug Administration approval of a supplemental new drug application (sNDA) for Qudexy XR (topiramate) extended-release capsules for use as initial monotherapy in patients two years of age and older who are experiencing partial-onset seizures (POS) or primary generalized tonic-clonic seizures.
People can become allergically sensitized straight from birth. "Early screening is therefore important to detect allergies early so that steps can be taken to prevent serious forms of illness developing," say the MedUni Vienna allergy researchers, speaking on the occasion of World Immunology Day on 29 April and the current WHO World Immunization Week.
The Senate is scheduled to proceed with consideration of the Obama administration pick to take over the Department of Health and Human Services.
› Verified 5 days ago
Hailey E Geoghegan, FNPC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 735 Wilson St, Brewer, ME 04412 Phone: 207-989-1567 Fax: 207-989-2286 | |
Cameron L Goller, FNPC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 735 Wilson St, Brewer, ME 04412 Phone: 207-989-1567 Fax: 207-989-2287 | |
Brooke A Morin, FNPC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 735 Wilson St, Brewer, ME 04412 Phone: 207-989-1567 Fax: 207-989-2286 | |
Amy A Langley, FNPC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 735 Wilson Street, Brewer, ME 04412 Phone: 207-992-2601 Fax: 207-989-2280 | |
Karrie Ann Ouellette, FNP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 33 Whiting Hill Rd, Brewer, ME 04412 Phone: 207-973-7478 | |
Janice L Pilotte, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 33 Whiting Hill Rd, Suite 21, Brewer, ME 04412 Phone: 207-973-7478 Fax: 207-973-7807 |